Editorial: Community series in reassessing the immune system contribution in multiple sclerosis: therapeutic target, biomarkers of disease and immune pathogenesis, volume II

Front Immunol. 2024 Nov 1:15:1505829. doi: 10.3389/fimmu.2024.1505829. eCollection 2024.
No abstract available

Keywords: Epstein-Barr virus (EBV); biomarkers; disease modified therapies; immune system; multiple sclerosis.

Publication types

  • Editorial